CYP19A1 and endometriosis: Therefore, there is significant interest in understanding and predicting the effects of therapies that perturb the cycle, such as gonadotropin-releasing hormone (GnRH) analogs, aromatase inhibitors, and progestins, on endometriosis and subfertility.